טוען...
Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: What have we learned?
The pharmacokinetics (PK) of therapeutic antibodies is determined by target and non-target mediated mechanisms. These antibody-specific factors need to be considered during prediction of human PK based upon preclinical information. Principles of allometric scaling established for small molecules usi...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Landes Bioscience
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3038012/ https://ncbi.nlm.nih.gov/pubmed/20962582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.3.1.13799 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|